HBV News and Research

RSS
CuraGen announces results with Belinostat and Velafermin

CuraGen announces results with Belinostat and Velafermin

Abbott opens biotech facility in Puerto Rico

Abbott opens biotech facility in Puerto Rico

Researchers document rare case of hepatitis B virus transmission

Researchers document rare case of hepatitis B virus transmission

Hepatitis B found in sweat of Olympic athletes

Hepatitis B found in sweat of Olympic athletes

FDA approves Tyzeka for the treatment of adults with chronic hepatitis B

FDA approves Tyzeka for the treatment of adults with chronic hepatitis B

Fewer deaths from cancer in the U.S.

Fewer deaths from cancer in the U.S.

Outcome of patients with hepatitis B and HIV infections referred for liver transplantation

Outcome of patients with hepatitis B and HIV infections referred for liver transplantation

$1.5 billion needed to cover years supply of pediatric vaccines

$1.5 billion needed to cover years supply of pediatric vaccines

New hepatitis drug much more effective

New hepatitis drug much more effective

Infants and adolescents vaccinated against hepatitis B are protected for over 10 years after immunisation

Infants and adolescents vaccinated against hepatitis B are protected for over 10 years after immunisation

Stressgen granted new U.S. patent for treatment of Hepatitis B

Stressgen granted new U.S. patent for treatment of Hepatitis B

Molecular link between a viral infection and development of a common and fatal form of liver cancer

Molecular link between a viral infection and development of a common and fatal form of liver cancer

Crucial molecular link between a hepatitis B virus (HBV) and hepatocellular carcinoma (HCC)

Crucial molecular link between a hepatitis B virus (HBV) and hepatocellular carcinoma (HCC)

Sirna Therapeutics granted new UK patents

Sirna Therapeutics granted new UK patents

Study shows using expanded critera donors is safe

Study shows using expanded critera donors is safe

BMA calls for mass child vaccinations for hepatitis B virus (HBV)

BMA calls for mass child vaccinations for hepatitis B virus (HBV)

New drug to treat chronic hepatitis B

New drug to treat chronic hepatitis B

Genetically engineered potatoes offer new hope in the fight against the Hepatitis B

Genetically engineered potatoes offer new hope in the fight against the Hepatitis B

Eleventh Edition of the Report on Carcinogens

Eleventh Edition of the Report on Carcinogens

Core promoter mutants of Hepatitis B Virus e Antigen associated with development of fulminant hepatitis and liver cancer

Core promoter mutants of Hepatitis B Virus e Antigen associated with development of fulminant hepatitis and liver cancer